[ENSC] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ENSC] Ensysce Biosciences, Inc.
Announcement Date
15-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 28.76%
YoY- -162.69%
Quarter Report
ENSC's Result
ENSC's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 515 435 490 790 1,433 279 207 83.30%
PBT -3,504 -2,691 -2,239 -2,192 -5,478 -9,856 -7,923 -41.86%
Tax 360 6 -3 -364 -2,912 3,666 906 -45.86%
NP -3,504 -2,690 -2,236 -1,828 -2,566 -13,521 -8,829 -45.90%
Tax Rate - - - - - - - -
Total Cost 4,019 3,125 2,726 2,618 4,000 13,801 9,037 -41.65%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -680.40 -617.75 -455.88 -231.53 -179.01 -4,840.31 -4,255.75 -70.44%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.55 -0.87 -0.98 -1.73 -8.46 -84.13 -62.35 -91.42%
EPS Diluted -1.55 -0.87 -0.98 -1.73 -8.46 -84.13 -62.35 -91.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.